| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |